feedback welcome


From Psychiatrynet

(Difference between revisions)
Jump to:navigation, search
[draft revision][draft revision]
(Redirected page to Maprotiline-citalopram)
Line 1: Line 1:
#redirect [[Maprotiline-citalopram]]
| from = maprotiline
| to = escitalopram
| stop =
* '''Before day 1:''' gradually reduce dosage of maprotiline to a maximum of 75 mg/day.
* '''Day 1:''' reduce dosage of maprotiline to 50 mg/day.
* '''Day 7:''' reduce dosage of maprotiline to 25 mg/day.
* '''Day 14:''' stop administration of maprotiline.
| start =
* '''Day 7:''' simultaneously start administration of escitalopram in a normal dosage of 10 mg/day.
| info =
* Escitalopram is a weak inhibitor of CYP2D6, which metabolizes maprotiline. 

Revision as of 22:37, 4 March 2010

Type Antidepressant
Group NRI
Medscape Maprotiline
PubChem 4011
PubMed Maprotiline
Kompas (Dutch) Maprotiline
Wikipedia Maprotiline
Type Antidepressant
Group SSRI
Medscape Escitalopram
PubChem 10832572
PubMed Escitalopram
Kompas (Dutch) Escitalopram
Wikipedia Escitalopram

Switch medication from maprotiline to escitalopram.

Nietinrijdenbord.png Stop maprotiline
Eenrichtingbord.png Start escitalopram
Infobord.png More information
The editors of take the greatest care to provide up-to-date and accurate information on this site. Nevertheless, mistakes and omissions cannot be entirely excluded. No rights devolve from the information provided. The editors and other providers of information to this site accept no responsibility for the content of this site or for the information provided therein; neither do they accept responsibility for possible damages which may derive from the use of the information on this site or from the linked sites. The editorial board accepts no responsibility for the content of the (linked) sites, for access to them, or for the products and services on these sites, nor for the occurrence of errors, viruses, and/or disruptions in service.